MoneyWorks4Me

Omkar Pharmachem - Quaterly Results

14 Feb 2024 Evaluate
Revenue showed a marginal decline at Rs. 1.35 millions. For the quarter ended December 2023, as compared to corresponding quarter of last year.The Company's Net profit for the December 2023 quarter have declined marginally to Rs. 0.67  millions as against Rs. 0.84 millions reported during the corresponding quarter ended.The Operating Profit of the company witnessed a decrease to 0.68 millions from 0.85 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 1.35 1.35 0.00 4.05 4.05 0.00 5.40 5.40 0.00
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.03 0.00 0.00
PBIDT 0.68 0.85 -20.00 2.09 2.08 0.48 3.13 2.68 16.79
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.46 0.56 -17.86
PBDT 0.68 0.85 -20.00 2.09 2.08 0.48 2.67 2.12 25.94
Depreciation 0.01 0.01 0.00 0.03 0.03 0.00 0.03 0.02 50.00
PBT 0.67 0.84 -20.24 2.06 2.05 0.49 2.64 2.10 25.71
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.67 0.27 148.15
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 0.67 0.84 -20.24 2.06 2.05 0.49 1.97 1.83 7.65
Equity 100.84 100.84 0.00 100.84 100.84 0.00 100.84 100.84 0.00
PBIDTM(%) 50.37 62.96 -20.00 51.60 51.36 0.48 57.96 49.63 16.79
Peers
Company Name CMP
Sagility 43.12
Prime Focus 301.65
Knowledge RealtyTrt. 112.24
Indegene 594.00
Syngene Internatl. 360.95
View more..